This Obesity Drug Stock Surges 60% on Phase 3 News
A notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
Knowing when to reassess your financial plan is key to success. Stay informed about the right times to make adjustments.
23,689 articlesA notable fund sold millions of dollars’ worth of shares as this obesity drug stock jumped on Phase 3 momentum. Here’...
A retiree explores how a $475,000 portfolio that quietly pays $2,800 a month relies on two overlooked income sources....
A new income model uses a $560,000 portfolio built from covered-call ETFs, preferred shares, and BDCS to generate abo...
Iren is pursuing a bold AI infrastructure push with a $4.4 billion target. This article breaks down what that means f...
A combo of macro headwinds and a bigger-than-expected debt offering pushed Ciena shares lower. This guide breaks down...
What if SpaceX and xAI merged to run data centers in orbit? This article breaks down how orbital compute could work, ...
As Camping World gears up for 2025, investors want clarity on growth, margins, and capital allocation. This analysis ...
A large investment pledge could reshape U.S. energy markets. This article explains what to watch and highlights two s...
As 2025 closes, KLX Energy Services faces a choppy energy market. This guide breaks down the Q4 2025 earnings landsca...
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
Nu Holdings approves a $1 billion share buyback, triggering a stock jump that investors will watch closely. Here’s wh...
A bold move blends football's global stage with crypto innovation. Kraken teams up with FIFA for World Cup 2026, aimi...